首页 | 本学科首页   官方微博 | 高级检索  
检索        

拉米夫定、水飞蓟滨治疗乙肝肝硬化临床研究
引用本文:冯慧琴,许祥稳,殳长林.拉米夫定、水飞蓟滨治疗乙肝肝硬化临床研究[J].实用全科医学,2010,8(1):55-55,124.
作者姓名:冯慧琴  许祥稳  殳长林
作者单位:浙江省桐乡市中医院内一病区,314500
摘    要:目的探讨拉米夫定联合水飞蓟滨对治疗乙型肝炎肝硬化指标变化的影响。方法将64例乙型肝炎肝硬化患者随机分为治疗组和对照组,治疗最少12个月,在治疗前、治疗后半年及治疗前、治疗后12个月测定肝纤维化指标及肝功能指标,进行相关性比较分析。结果治疗组肝纤维化及肝功能指标下降明显优于对照组,差异具有统计学意义(P〈0.05);同时其AST治疗组1年后与半年君比较AST下降明显,其疗效与疗程呈相关性。结论拉米夫定联合水飞蓟滨能明显改善乙肝肝硬化患者肝纤维化指标及肝功能指标。

关 键 词:乙肝  肝硬化  拉米夫定  水飞蓟滨

Clinical Effect of Lamivudine with Silibinin for Liver Cirrhosis
FENG Hui-qin,XU Xiang-wen,SHU Chang-lin.Clinical Effect of Lamivudine with Silibinin for Liver Cirrhosis[J].Applied Journal Of General Practice,2010,8(1):55-55,124.
Authors:FENG Hui-qin  XU Xiang-wen  SHU Chang-lin
Institution:FENG Hui-qin,XU Xiang-wen,SHU Chang-lin.Department of Internal Medicine,Tongxiang Chinese Medicine Hospital,Tongxiang 314500,Zhejiang,China
Abstract:Objective To observe the curative effect of silibinin combined with lamivudine for liver cirrhosis in patients with hepatitis B.Methods 64 cases with hepatitis B liver cirrhosis were randomly divided into treatment group and control group.At 12 months and 6 months before and after the treatment,the liver fibrosis and liver function indicators were determined and compared.Results The indicator of liver fibrosis and liver function of the treatment group decline slowly than that of the control group(P<0.05).In...
Keywords:Hepatitis B  Liver cirrhosis  Lamivudine  Silibinin  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号